Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
4 hedge funds and large institutions have $222K invested in Nemaura Medical, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$110K |
| 2 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$66.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $95K | +$110K | +2,083 | New |
|
|
SC
2
Scotia Capital
Toronto,
Ontario, Canada
| $57K | +$66.3K | +1,250 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $56K | +$65.8K | +1,240 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $14K | +$16.5K | +311 | New |
|
NMRD Hedge Fund Activity: Q1 2018 in Review
4 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2018, worth a combined $222K.
Buyers outnumbered sellers: 4 funds opened new NMRD positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $110K.
- 4 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2018, up from 0 in Q4 2017.
- Funds reported $222K of Nemaura Medical, Inc. Common Stock stock for Q1 2018.
- 4 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2018 and 0 closed out, a net change of +4 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2018 was Bank of America, an estimated $110K added.
Based on aggregated 13F filings for Q1 2018.